Endothelium and valvular diseases of the heart
β Scribed by Richard L. Leask; Neelesh Jain; Jagdish Butany
- Book ID
- 102888438
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 818 KB
- Volume
- 60
- Category
- Article
- ISSN
- 1059-910X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
It has become increasingly evident that the endothelium plays a critical role in the pathogenesis of valvular heart disease. The endothelium helps regulate vascular tone, inflammation, thrombosis, and vascular remodeling. Dysfunction of the endothelial cells has been linked to many vascular disorders including atherosclerosis. Common valvular diseases such as senile degenerative valve disease, myxomatous (or floppy) valves, rheumatic valves, and infective endocarditis valves show changes in the synthetic, morphologic, and metabolic functions of the valvular endothelial cells. These diseases are active processes related to endothelial cell dysfunction. Endothelial cell dysfunction is caused by mechanical forces, bacterial infection, autoantibodies, and circulating modulators of endothelial cell function. This study reviews the role of endothelial cell dysfunction in the more common valvular diseases. Continued research on endothelial cell dysfunction is crucial to our understanding of valvular heart diseases and may elucidate novel treatment and prevention strategies. Microsc. Res. Tech. 60:129β137, 2003. Β© 2003 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract It has been reported that patients on pergolide and carbergoline have an increased risk of developing valvular heart disease. It is uncertain if bromocriptine, an ergotβderived dopamine agonist (DA) with partial 5βHT~2B~ activity, is associated with a similar risk. We assessed the frequ
## Abstract Companion letters have been published in this issue of __Movement__ Disorders: Chaudhuri et al., pp 1522β1523, and Horowski et al., pp 1523β1524.